~12 spots leftby Aug 2025

Mindfulness for Reducing Colorectal Cancer Risk

(MindCRC Trial)

Recruiting in Palo Alto (17 mi)
+1 other location
Age: 18+
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of Illinois at Chicago
Must not be taking: Antibiotics, Corticosteroids, others
Disqualifiers: History of CRC, Cancer, Diabetes, others
No Placebo Group
Approved in 3 Jurisdictions

Trial Summary

What is the purpose of this trial?

Many neighborhoods in Chicago experience daily exposure to stressors including economic inopportunity and violent crime in public spaces. There is mounting evidence that chronic psychosocial stress can facilitate carcinogenesis by modulating the gut microbiome and immune system. The proposed research aims to study the practice of mindfulness to mitigate CPS and reduce colorectal cancer risk factors among Black American women at elevated risk.

Will I have to stop taking my current medications?

The trial does not specify if you must stop taking your current medications, but it excludes those taking certain medications like β-blockers and corticosteroids. It's best to discuss your specific medications with the trial team.

What data supports the effectiveness of the treatment Mindfulness-Based Interventions for reducing colorectal cancer risk?

Research shows that mindfulness-based interventions can help reduce psychological distress in cancer patients, which may support overall health and recovery. Specifically, mindfulness-based stress reduction has been used effectively alongside chemotherapy in colorectal cancer care to improve patient outcomes.12345

Is mindfulness safe for humans?

Mindfulness practices like Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT) have been widely studied and are generally considered safe for humans, with no significant safety concerns reported in the research.23678

How does the treatment Mindfulness differ from other treatments for reducing colorectal cancer risk?

Mindfulness is unique because it focuses on reducing stress and improving mental well-being, which can lead to healthier lifestyle choices that may lower colorectal cancer risk. Unlike traditional treatments that involve drugs or invasive procedures, mindfulness uses techniques like meditation and cognitive therapy to promote overall health and potentially prevent cancer.910111213

Research Team

Eligibility Criteria

This trial is for Black American women at an elevated risk of colorectal cancer who live in high-stress neighborhoods in Chicago. Participants should be interested in practicing mindfulness to potentially reduce their cancer risk.

Inclusion Criteria

Self-identify as Black
Completed a colonoscopy in the past 12 months
Score ≥ 14 on the PSS at screening
See 5 more

Exclusion Criteria

Consume > 50 grams of ethanol daily
Use combustible tobacco
I have had weight loss surgery or part of my bowel removed.
See 9 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Mindfulness Intervention

Participants undergo an 8-week mindfulness intervention delivered in a hybrid format, including both group and individual mindfulness training and practice.

8 weeks
Synchronous and asynchronous sessions

Follow-up

Participants are monitored for changes in stress, weight, glucose, inflammation markers, and gut microbiome composition after the intervention.

1 week
Post-intervention assessments

Treatment Details

Interventions

  • Mindfulness (Behavioral Intervention)
Trial OverviewThe study is testing whether practicing mindfulness can help lower chronic psychosocial stress (CPS) and, as a result, reduce the risk factors associated with colorectal cancer development.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: MindfulnessExperimental Treatment1 Intervention
8-week group and individual mindfulness training and practice

Mindfulness is already approved in Canada for the following indications:

🇨🇦
Approved in Canada as Mindfulness-Based Cognitive Therapy for:
  • Depression
  • Anxiety Disorders
  • Substance Abuse Treatment

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+
Mark I. Rosenblatt profile image

Mark I. Rosenblatt

University of Illinois at Chicago

Chief Executive Officer

MD, PhD, MBA, MHA

Jon Radosta profile image

Jon Radosta

University of Illinois at Chicago

Chief Medical Officer since 2023

MD

Findings from Research

Mindfulness-based interventions (MBIs) significantly reduce psychological distress in cancer patients and survivors, with a small but meaningful effect size (Hedges's g = 0.32) observed immediately after the intervention and a sustained effect (g = 0.19) at follow-up, based on a systematic review of 29 randomized controlled trials involving 3274 participants.
MBIs also positively impact secondary outcomes such as anxiety, depression, and sleep disturbances, with larger effects noted in studies that adhered closely to MBI protocols and involved younger participants, indicating that optimizing these interventions could enhance their efficacy.
Mindfulness-based interventions for psychological and physical health outcomes in cancer patients and survivors: A systematic review and meta-analysis of randomized controlled trials.Cillessen, L., Johannsen, M., Speckens, AEM., et al.[2021]
In a study of 88 colorectal cancer patients undergoing chemotherapy, the addition of mindfulness-based stress reduction (MBSR) to standard care improved psychological well-being, treatment compliance, and self-care abilities compared to conventional care alone.
While the overall response rate and adverse events were similar between the MBSR and control groups, the MBSR group showed higher rates of improvement in functional status and quality of life after one year, indicating its potential benefit in enhancing patient rehabilitation during chemotherapy.
Clinical Efficacy of Bevacizumab Plus XELOX Chemotherapy in Colorectal Cancer and Application Value of Mindfulness-Based Stress Reduction Intervention.Sun, L., Zhang, X., Gong, P., et al.[2022]
Both group face-to-face mindfulness-based cognitive therapy (MBCT) and individual internet-based mindfulness-based cognitive therapy (eMBCT) led to long-term reductions in psychological distress and increases in mental health-related quality of life over a nine-month follow-up period for 245 distressed cancer patients.
Patients who participated in eMBCT reported lower psychological distress compared to those in MBCT, particularly benefiting those with lower baseline mindfulness and conscientiousness, suggesting that eMBCT may be a more effective option for certain individuals.
Consolidation and prediction of long-term treatment effect of group and online mindfulness-based cognitive therapy for distressed cancer patients.Cillessen, L., Schellekens, MPJ., Van de Ven, MOM., et al.[2019]

References

Mindfulness-based interventions for psychological and physical health outcomes in cancer patients and survivors: A systematic review and meta-analysis of randomized controlled trials. [2021]
Clinical Efficacy of Bevacizumab Plus XELOX Chemotherapy in Colorectal Cancer and Application Value of Mindfulness-Based Stress Reduction Intervention. [2022]
Mindfulness-based stress reduction for breast cancer-a systematic review and meta-analysis. [2021]
Consolidation and prediction of long-term treatment effect of group and online mindfulness-based cognitive therapy for distressed cancer patients. [2019]
Mindfulness-Based Stress Reduction as supportive therapy in cancer care: systematic review. [2018]
Being mindful of mindfulness interventions in cancer: A systematic review of intervention reporting and study methodology. [2019]
Mindfulness-based stress reduction and mindfulness-based cognitive therapy: a systematic review of randomized controlled trials. [2022]
Mindfulness based intervention through mobile app for colorectal cancer people awaiting surgery: A randomized clinical trial. [2022]
Review article: the prevention of colorectal cancer. [2019]
The clinical utility of a comprehensive psychosomatic assessment in the program for colorectal cancer prevention: a cross-sectional study. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
Colorectal cancer: what should patients and families be told to lower the risk of colorectal cancer? [2010]
12.United Statespubmed.ncbi.nlm.nih.gov
The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. [2022]
Strategies for colon cancer prevention. [2021]